Good Morning, Traders!…👋

U.S. stock futures climbed on Tuesday, signaling the potential start of a recovery from another sharp sell-off as concerns over economic growth continued to weigh on investor sentiment.

The mood on Wall Street has grown increasingly bleak as President Donald Trump presses forward with his aggressive trade war, despite growing concerns about the health of the U.S. economy. Monday's market meltdown coincided with a shift in investors' views on economic growth, as firms like Goldman Sachs slashed their economic forecasts.

Delta Airlines $DAL ( ▼ 1.23% ) cut its outlook for the current quarter late Monday, citing "macro uncertainty" as an early sign of how the gloomy economic mood could impact corporate performance this year. Shares of the airline tumbled in premarket trading. Investors are bracing for a pulse check on inflation later this week, with February’s Consumer Price Index (CPI) report due Wednesday and the Producer Price Index (PPI) set for release on Thursday.

Happening Today

✓ 10:00 AM ET – JOLTS Job Openings (Jan)

✓ 12:00 PM ET – EIA Short-Term Energy Outlook

✓ 12:00 PM ET – WASDE Report

✓ 01:00 PM ET – 3-Year Note Auction

PREMARKET SNAPSHOT 📈

​As of March 11, 2025, the S&P 500 is at 5,642.50, up 0.39%; the Dow Jones Industrial Average is at 42,070.00, up 0.29%; and the NASDAQ Composite is at 19,549.75, up 0.50%.​

SECTOR SNAPSHOT✨

Yesterday market faced heavy selling pressure, with technology and communication services leading the downturn. Consumer discretionary and financials also saw steep losses, while healthcare, industrials, and materials struggled. Energy remained resilient with modest gains, and utilities managed to stay positive, benefiting from defensive positioning. Real estate continued to slide amid broader market weakness.

PreMarket Unusual Volume Stocks

📈 Sonoma Pharmaceuticals, Inc. $SNOA ( ▼ 3.39% )  is seeing a remarkable pre-market rally, surging 27.96% to $2.79. The stock has traded 3.24 million shares in pre-market activity, reflecting an astonishing 98,970.11% increase in volume.

📈 Tenon Medical, Inc. $TNON ( ▼ 35.47% ) is making a strong pre-market surge, climbing 52.80% to $1.25. The stock has traded 8.6 million shares in pre-market activity, reflecting an extraordinary 13,769.12% increase in volume. This sharp spike suggests heightened investor interest, likely fueled by company-specific developments or broader market trends in the medical sector.

📈 BIO-key International, Inc. $BKYI ( ▲ 2.75% ) is up 7.27% in pre-market trading, now priced at $1.10. The stock has recorded a notable volume of 192.19K shares, marking a 2,815.16% surge compared to its average. This move indicates growing attention, potentially tied to cybersecurity industry momentum or recent company advancements.

📈 Aspira Women's Health Inc. $AWH ( ▲ 18.18% ) is one of the top pre-market gainers, soaring 117.93% to $0.1980. Trading volume has surged to 57.8 million shares, representing a 280.85% increase. This substantial activity suggests strong speculative interest, possibly driven by clinical updates or broader healthcare sector movements.

📈 2seventy bio, Inc. $TSVT ( ▲ 0.2% ) is experiencing a major pre-market rally, jumping 76.79% to $2.80. With 389.39K shares traded—a 270.51% increase—the biotech stock is drawing strong interest. Investors are likely reacting to industry news or company-specific catalysts.

Premarket Picks

Tenon Medical, Inc. (TNON) saw a pre-market price of $1.93, reflecting a surge of 54.40%. This surge was driven by the company’s receipt of a Notice of Allowance from the European Patent Office.

2seventy bio, Inc. (TSVT) traded at $4.95 in the pre-market, surging 76.79%. The increase came after the company entered into a definitive agreement to be acquired by Bristol Myers Squibb.

Sonoma Pharmaceuticals, Inc. (SNOA) reached a pre-market price of $3.44, up by 23.29%. This rise followed the announcement that the company had registered its manufacturing facility and five products with the UK’s Medicines & Healthcare products Regulatory Agency (MHRA).

LifeMD, Inc. (LFMD) saw a pre-market price of $5.20, a gain of 21.78%. This surge was attributed to the company’s strong financial results for 2024, with consolidated revenues up 43% year-over-year and a 60% increase in telehealth revenue.

Below is a complete list of hot stocks in pre-market today:

Top Upgrades:

1. TXNM Energy, Inc. $TXNM ( ▼ 0.82% ) 

Analyst Firm: Mizuho
Upgraded: Neutral to Outperform
Price Target: $53
Yesterday's Close: $47.87

Mizuho analyst upgraded TXNM Energy, Inc. (TXNM) to Outperform from Neutral, setting a price target of $53. The stock price target for TXNM Energy, Inc. is set with a high of $58.00, a median of $55.50, and a low of $53.00. The average target price is $55.38. TXNM Energy provides electricity and electric services through its subsidiaries across the United States.

2. GE HealthCare Technologies Inc. $GEHC ( ▼ 1.77% )  

Analyst Firm: Goldman Sachs
Upgraded: Neutral to Buy
Price Target: $100
Yesterday's Close: $85.36

Goldman Sachs analyst moved GE HealthCare Technologies Inc. (GEHC) from Neutral to Buy, with a price target of $100. For GE HealthCare Technologies Inc., the stock price target ranges from a high of $115.00 to a low of $86.00, with a median of $103.50. The average target price is $102.88. GE HealthCare focuses on developing and marketing products and digital solutions for patient care worldwide.

3. Capital One Financial Corporation $COF ( ▼ 1.43% )  

Analyst Firm: Baird
Upgraded: Neutral to Outperform
Price Target: $200
Yesterday's Close: $163.87

Baird raised its rating on Capital One (COF) to Outperform from Neutral, increasing the price target to $200 from $190. The stock price target for Capital One Financial Corporation is set with a high of $257.00, a median of $224.50, and a low of $176.00. The average target price is $222.28. Capital One is the parent company of Capital One, offering financial products and services in the U.S., Canada, and the UK.

Happy investing,

Maeve Grace
Editor In Chief
Premium Stock Alerts

Important: This newsletter does not provide investment advice. The stocks mentioned should not be taken as recommendations. Your investments are solely your decisions.

Disclosure: I hold no positions in any companies mentioned, either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article.